Screening compound: IWZQPZZNBSRXNY-UHFFFAOYSA-N

Screening compound: IWZQPZZNBSRXNY-UHFFFAOYSA-N
Screening compound: IWZQPZZNBSRXNY-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
IWZQPZZNBSRXNY-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E525-0625

Molecular Formula

C29H43N5O2 (C29 H43 N5 O2)

Compound Name

2-[3-(1-azepanyl)propyl]-N~3~-(2,3-dimethylcyclohexyl)-3-methyl-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-3-carboxamide

IUPAC name

11-[3-(azepan-1-yl)propyl]-N-(23-dimethylcyclohexyl)-12-methyl-10-oxo-1811-triazatricyclo[7.4.0.0^{27}]trideca-2468-tetraene-12-carboxamide

SMILES

CC(CCC1)C(C)C1NC(C(C)(Cn1c2nc3c1cccc3)N(CCCN1CCCCCC1)C2=O)=O

InChI

InChI=1S/C29H43N5O2/c1-21-12-10-14-23(22(21)2)31-28(36)29(3)20-33-25-15-7-6-13-24(25)30-26(33)27(35)34(29)19-11-18-32-16-8-4-5-9-17-32/h6-7,13,15,21-23H,4-5,8-12,14,16-20H2,1-3H3,(H,31,36)

InChI Key

IWZQPZZNBSRXNY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14895223

IWZQPZZNBSRXNY-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Cyclic Ugi PPI Library (9586 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with IWZQPZZNBSRXNY-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound IWZQPZZNBSRXNY-UHFFFAOYSA-N?
Check Price and Availability of IWZQPZZNBSRXNY-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of IWZQPZZNBSRXNY-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for IWZQPZZNBSRXNY-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for IWZQPZZNBSRXNY-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of IWZQPZZNBSRXNY-UHFFFAOYSA-N available by request